Moderna said Wednesday that its experimental mRNA-based seasonal flu vaccine generated a stronger immune response against four strains of the flu virus than a currently marketed vaccine in a Phase 3 ...

A biochemist born in Hungary and an American immunologist have won the 2023 Nobel Prize for Physiology or Medicine for research that led to the development of the two most important COVID-19 vaccines.

June 29 (Reuters) - Sanofi (SASY.PA), opens new tab said that trials show the currently available mRNA technology behind the most successful COVID-19 shots will not be effective against influenza and ...

Generation LNP Advancements enhance potency and safety, expand delivery beyond the liver, and enable broader therapeutic ...

Moderna Inc (NASDAQ:MRNA) stock closed lower by 2.32% on Wednesday, as news around Arbutus Biopharma (NASDAQ:ABUS) impacted investor sentiment. Arbutus has received permission to pursue its patent ...